* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Download Please Highlight this Area and Add your Main Title
Survey
Document related concepts
Pharmacogenomics wikipedia , lookup
Prescription costs wikipedia , lookup
Cannabinoid receptor antagonist wikipedia , lookup
Drug discovery wikipedia , lookup
Drug design wikipedia , lookup
Discovery and development of angiotensin receptor blockers wikipedia , lookup
Drug interaction wikipedia , lookup
Zoopharmacognosy wikipedia , lookup
Pharmacokinetics wikipedia , lookup
Urban legends about drugs wikipedia , lookup
NK1 receptor antagonist wikipedia , lookup
Psychopharmacology wikipedia , lookup
Neuropharmacology wikipedia , lookup
Neuropsychopharmacology wikipedia , lookup
Transcript
Prazosin Attenuates the Unconditioned and Conditioned Hyperactive Effects of Methamphetamine and Neuroscience 15000 9000 8000 4 Days — Days 2, 4, 6, 8 7000 6000 5000 4000 * 3000 # Veh/Meth 0.5 Praz/Meth 1.0 Praz/Meth 2.0 Praz/Meth 1750 1500 1250 1000 2000 750 * 500 # 1000 250 0 0 0 0.5 1.0 2.0 # *# 0 Non-drug Days: Injection (SC) of either vehicle (saline) or methamphetamine (1.0 mg/kg, SC) for paired and unpaired animals, respectively, in their home cages. Veh/Veh 0.5 Praz/Veh 1.0 Praz/Veh 2.0 Praz/Veh 1750 5 10 25 *# 750 # 500 # 0 0 30 5 10 15 20 25 30 Session Minute Session Minute 30 minute session in activity chamber s following vehicle (saline) injection for all mice Introduction 2500 10000 * 8000 6000 # 4000 o Prazosin, an α1 receptor antagonist, blocks the locomotor-activating effects of amphetamine in rats (Darraq et al., 1998; Drouin et al., 2002 Snoddy & Tessel, 1985). Depletion of norepinephrine from the medial prefrontal cortex abolishes amphetamine-produced conditioned place preference in mice (Ventura et al., 2003). Test Day 2: Methamphetamine challenge 1 Day - Day 10 30 minute session in activity chamber following methamphetamine (1.0 mg/kg) injection for all mice Little research, however, has examined the contribution of the noradrenergic, α1 receptor system, in mediating the unconditioned and conditioned hyperactive effects of methamphetamine in mice. # # 1500 1000 0 2000 1500 0.5 1.0 500 0 0 2.0 $# 1000 0 0 5 10 15 20 25 30 0 5 10 Session Minute Prazosin Dose (mg/kg) 15 20 25 30 Session Minute Paired mice pretreated with the moderate (1.0 mg/kg) and high (2.0 mg/kg) prazosin doses showed significantly less locomotor activity compared to veh-meth paired control mice (left and middle panels). The low (0.5 mg/kg) and high (2.0 mg/kg) prazosin doses decreased locomotor activity in the unpaired mice compared to their respective veh-veh control group during the first 5 minute of the session (right panel). * = difference of 1.0 mg/kg prazosin relative to their respective vehicle control group, p < 0.05. # = difference of 2.0 mg/kg prazosin relative to their respective vehicle control group, p < 0.05. $ = difference of 0.5 mg/kg prazosin relative to their respective vehicle control group, p < 0.05 Test Day 1: Conditioning Test Objective The present experiment examined the ability of the α1 receptor antagonist, prazosin, to attenuate the unconditioned and conditioned hyperactive effects of methamphetamine. 6000 Distance Traveled Distance Traveled (cm) Veh/Meth 0.5 Praz/Meth 1.0 Praz/Meth 2.0 Praz/Meth 1750 5000 4000 3000 2000 1500 1250 1000 750 Veh/Veh 0.5 Praz/Veh 1.0 Praz/Veh 2.0 Praz/Veh 1750 1500 1250 750 * 1.0 2.0 Prazosin Dose (mg/kg) 500 0 0 5 10 15 20 25 30 0 5 Session Minute 10 15 25 30 Discussion Prazosin dose dependently attenuated the hyperactive effects of methamphetamine following acute (Day 1) and repeated (Day 4) administrations. The 1.0 mg/kg prazosin dose attenuated the hyperactive effect of methamphetamine without disrupting activity in unpaired control mice. These results are consistent with previous studies that have reported that prazosin dose dependently attenuates the hyperactive effects of amphetamine (Snoddy & Tessel, 1985; Darraq et al., 1998; Drouin et al., 2002). On Days 1 and 4, the high prazosin dose (2.0 mg/kg) did decrease behavior in Unpaired mice, suggesting that this dose non-specifically decreased locomotor activity. However, On Test Day 1 (Conditioning Test), paired mice pretreated with the moderate (1.0 mg/kg) and high (2.0 mg/kg) prazosin doses during conditioning did not differ from their unpaired counterparts, suggesting that these doses attenuated the conditioned hyperactive response . Moreover, the 2.0 mg/kg prazosin dose did not decrease behavior in unpaired mice on Test Day 1, suggesting that attenuated conditioned hyperactive response was not due to drug-induced disruptions in behavior. Collectively, these results suggest that the α1 receptor system contributes to the unconditioned and conditioned hyperactive effects of methamphetamine and further supports the role of the noradrenergic α1 receptor system in mediating the unconditioned and conditioned effects of psychostimulants. References 1. Beninger, R.J., & Hahn, B. L. (1983). Pimozide blocks establishment but not the expression of amphetamine-produced environment-specific conditioning. Science, 220:1304-1306. 2. Darraq, L., Blanc, G., Glowinski, J., & Tassin, J-P. (1998). Importance of the noradrenalindopamine coupling in the locomotor-activating effects of d-amphetamine. Journal of Neuroscience, 18: 2729-2739. 5. Mazurski, E. J., & Beninger, R. J. (1991). Effects of selective drugs for dopaminergic D1 and D2 receptors on conditioned locomotion in rats. Psychopharmacology, 105:107-112. 0 0 0 5 10 15 20 Session Minute 25 30 0 5 10 15 20 25 30 Session Minute Acknowledgements Locomotor Activity Chamber 20 Session Minute 7. Weinshenker, D. & Schroeder, J.P. (2007). There and back again: a tale of norepinephrine and drug addiction. Neuropsychopharmacology, 32: 1433-1451. 250 250 0.5 1000 6. Snoddy, A.M. & Tessel (1985). Prazosin: effect of psychomotor-stimulant cues and locomotor activity in mice. European Journal of Pharmacology, 116: 221-228. 1000 1000 0 2.0 1500 4. Duteil, J., Rambert, F.A., Pessonnier, J., Hermant, J-F., Gombert, R., & Assous, E. (1990). Central α-1 adrenergic stimulation in relation to the behavior stimulating effect of modafinil; studies with experimental animals. European Journal of Pharmacology, 180: 49-58. 500 # 500 0 1.0 2000 2000 2000 Unpaired Paired 1000 2500 3. Drouin, C., Darraq, L., Trovero, F., Blanc, G., Glowinski, J., Cotecchia, S., Tassin, J-P. (2002). Journal of Neuroscience, 22: 2873-2884. Test Day 2 (Unpaired Groups Only) Test Day 1 (Paired Groups Only) Test Day 1 (Conditioning Test) Hypothesis Because the α1 receptor system has been shown to be involved in mediating the unconditioned and conditioned effects of other psychostimulants (e.g., amphetamine; see Weinshaker and Schoeder, 2007, for a review), it was predicted that prazosin, a selective α1 noradrenergic receptor antagonist (Duteil et al. 1990), should dose-dependently attenuate the unconditioned and conditioned hyperactive effects of methamphetamine. # 500 Support for this view comes from a number of studies o # 2000 2000 24 h *# * # Veh/Veh 0.5 Praz/Veh 1.0 Praz/Veh 2.0 Praz/Veh 2500 Distance Traveled (cm) 12000 3000 Veh/Meth 0.5 Praz/Meth 1.0 Praz/Meth 2.0 Praz/Meth Distance Traveled research has suggested that the noradrenergic system, particularly the α1 receptor system, interacts with the dopaminergic system and contributes to the unconditioned and conditioned hyperactive effects of psychostimulants (see Weinshaker and Schoeder, 2007, for a review). 1 Day - Day 9 Drug Day 4 (Unpaired Groups) Drug Day 4 (Paired Groups) 3000 Unpaired Paired Distance Traveled (cm) Recent 14000 Distance Traveled (cm) and conditioned hyperactive effects of psychostimulants has been well established (Beninger and Hahn, 1983; Mazurski and Beninger, 1991) Drug Day 4 (Repeated Methamphetamine) # # Veh/Veh 0.5 Praz/Veh 1.0 Praz/Veh 2.0 Praz/Veh Only paired mice that were pretreated with veh-meth during conditioning differed from their unpaired counterparts (veh-veh; left panel), suggesting that all prazosin doses attenuated the challenge with methamphetamine. Paired mice that were pretreated with the high prazosin dose (2.0 mg/kg) differed from their veh-meth paired control mice (middle panel). Group differences were not detected in unpaired mice (right panel). # = difference of 2.0 mg/kg prazosin relative to respective control group, p < 0.05. # Drug Day 4 Test Day 1: Conditioning Test 1500 0 0.5 3000 1000 24 h The role of the mesolimbic dopamine system in mediating the unconditioned 2000 500 Prazosin Dose (mg/kg) Paired mice pretreated with moderate (1.0 mg/kg) and high (2.0 mg/kg) prazosin showed significantly less locomotor activity compared to their veh-meth paired control mice (left and middle panels). However, these prazosin doses also produced a decrease in locomotor activity in unpaired mice relative to their veh-veh unpaired control group (left and right panels). * = difference of 1.0 mg/kg prazosin relative to respective vehicle group, p < 0.05. # = difference of 2.0 mg/kg prazosin relative to respective vehicle control group, p < 0.05. $ = difference of 0.5 mg/kg prazosin relative to respective vehicle control group, p < 0.05. Introduction 5000 0 1250 * # *# *# *# 20 7500 0 1500 250 15 10000 Methamphetamine Challenge (Unpaired Groups Only) Veh/Meth 0.5 Praz/Meth 1.0 Praz/Meth 2.0 Praz/Meth 2500 2500 $# Prazosin Dose (mg/kg) Drug Days: Injection (IP) of vehicle (dH20) or prazosin (0.5, 1.0, or 2.0 mg/kg, IP) followed 30 minutes later by an injection (SC) of vehicle (saline; Unpaired) or methamphetamine (1.0 mg/kg; Paired). Then, all mice were placed in the activity chambers for a 30-minute session. Drug Day 1 (Unpaired Groups) 2000 2000 Unpaired Paired Distance Travelled (cm) 7 Days 3000 12500 Drug Day 1 (Paired Groups) Drug Day 1 (Acute Methamphetamine) Methamphetamine Challenge (Paired Groups Only) Test Day 2 (Methamphetamine Challenge) Unpaired Paired Drug Day 1 Acclimation (Handling) 4 Days — Days 1, 3, 5, 7 Test Day 2: Methamphetamine Challenge Results Procedure Conditioning: Non-drug days Dickinson College, Carlisle, PA Distance Traveled Methods Conditioning: Drug days 2 Program , Distance Traveled Department of Distance Traveled (cm) The present experiment determined the ability of the α1-noradrenergic receptor antagonist, prazosin, to attenuate the unconditioned and conditioned hyperactive effects in male Swiss-Webster mice. After the initial acclimation period (7 days), the experiment lasted 10 days and consisted of 2 phases (Conditioning and Tests). The Conditioning Phase lasted 8 days and consisted of 4 alternating Drug and Non-drug days. During Drug Days, mice were injected (IP) with vehicle (dH2O) or prazosin (0.5, 1.0, or 2.0 mg/kg) followed 30 minutes later by an injection (SC) of either vehicle (saline; Unpaired mice) or methamphetamine (1.0 mg/kg; Paired mice) before entering the activity chamber for a 30-minute session. On Non-drug Days, mice remained in their home cages and received an injection (SC) of vehicle (physiological saline; Paired) or methamphetamine (1.0 mg/kg; Unpaired). The tests for conditioned hyperactivity (Test Day 1) and methamphetamine sensitization (Test Day 2) occurred 48 and 72 hours following the last drug days, respectively. On Test Days 1 and 2, all mice were injected with vehicle or methamphetamine (1.0 mg/kg), respectively. Prazosin dose-dependently attenuated with unconditioned and conditioned hyperactive effects of methamphetamine. These results suggest the α1 receptor contributes to the development of the unconditioned (i.e., pharmacological) and conditioned hyperactive (i.e., learned) effects of methamphetamine. 1 Psychology Distance Traveled (cm) Abstract and Anthony S. Rauhut 1,2, Distance Traveled (cm) Margaret Della 2 Vecchia Paired mice pretreated with the moderate (1.0 mg/kg) or the high (2.0 mg/kg) prazosin doses during conditioning did not differ from their unpaired counterparts (left panel). Paired mice pretreated the high prazosin dose (2.0 mg/kg) during conditioning did not differ from methamphetamine paired control mice. # = difference of 2.0 mg/kg prazosin relative to their respective control group, p < 0.05. This research was supported by a National Institutes of Health grant (DA019866), awarded to A. S. Rauhut, and “matching funds” provided by Dickinson College.